Listen to this page using ReadSpeaker


Merz Pharmaceuticals is a specialty healthcare company
that develops and commercializes innovative treatment
solutions in aesthetics, dermatology and neurology
in the U.S. and Canada. Our ambition is to become
a recognized leader in the treatment of movement
disorders, and in aesthetics and dermatology. Our future
is promising, and we are committed to advancing new
therapeutic options and improving patients’ lives. For
more than 100 years, the development of our products
has been based on Merz‘s commitment to providing
innovative medical approaches that earn trust of
patients, physicians and partners worldwide. Globally,
the companies of Merz Pharma Group are focused on
medications for treating neurological and psychiatric
illnesses, and they have assumed a leading role in the
field of Alzheimer’s disease research. Founded in 1908,
Merz Pharma Group is a privately owned company
headquartered in Frankfurt, Germany. For more
information, visit www.merzusa.com.